Target Name: OR13F1
NCBI ID: G138805
Review Report on OR13F1 Target / Biomarker Content of Review Report on OR13F1 Target / Biomarker
OR13F1
Other Name(s): olfactory receptor family 13 subfamily F member 1 | OR9-6 | olfactory receptor OR9-6 | Olfactory receptor, family 13, subfamily F, member 1 | Olfactory receptor 13F1 | Olfactory receptor family 13 subfamily F member 1 | O13F1_HUMAN | OTTHUMP00000021822 | Olfactory receptor OR9-6

OR13F1: A Potential Drug Target Or Biomarker

OR13F1, also known as olfactory receptor family 13 subfamily F member 1, is a protein that is expressed in the olfactory system of the human body. OR13F1 plays a crucial role in the sense of smell, as it is responsible for the recognition of scents.

Recent studies have suggested that OR13F1 may be a drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. This has led to a growing interest in the research of OR13F1 and its potential applications in drug development.

One of the potential reasons for the interest in OR13F1 is its involvement in the development and progression of cancer. OR13F1 has been shown to be expressed in various types of cancer, including breast, ovarian, and prostate cancer. Additionally, studies have shown that inhibiting OR13F1 can lead to a reduction in the growth and spread of cancer cells.

Another potential application of OR13F1 is its role in neurodegenerative diseases. OR13F1 is expressed in the brains of individuals with Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders. Studies have shown that reducing OR13F1 expression can improve the progression of these diseases.

OR13F1 has also been shown to be involved in psychiatric disorders, including depression and anxiety. Studies have shown that individuals with major depressive disorder (MDD) and anxiety disorder (ADHD) have lower levels of OR13F1 in their brains. Additionally, individuals with these disorders have been shown to have reduced responses to neurotransmitters, such as dopamine and serotonin, which are involved in mood and anxiety.

In addition to its potential as a drug target or biomarker, OR13F1 has also been shown to be involved in various other physiological processes in the body. For example, OR13F1 is involved in the sense of taste, as it is a key receptor for the taste of sweet and sour flavors. OR13F1 is also involved in the regulation of body temperature, as it is expressed in the sweat glands and is responsible for regulating the body's temperature.

Given the potential involvement of OR13F1 in various diseases and physiological processes, research into its potential applications in drug development and other fields is of high interest. Further studies are needed to fully understand the role of OR13F1 in these areas and to develop new treatments based on its properties.

In conclusion, OR13F1 is a protein that is expressed in the olfactory system of the human body that plays a crucial role in the sense of smell. Recent studies have suggested that OR13F1 may be a drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. Further research is needed to fully understand the role of OR13F1 in these areas and to develop new treatments based on its properties.

Protein Name: Olfactory Receptor Family 13 Subfamily F Member 1

Functions: Odorant receptor

The "OR13F1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR13F1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR13G1 | OR13H1 | OR13J1 | OR13Z2P | OR14A16 | OR14A2 | OR14C36 | OR14I1 | OR14J1 | OR14L1P | OR1A1 | OR1A2 | OR1B1 | OR1C1 | OR1D2 | OR1D4 | OR1D5 | OR1E1 | OR1E2 | OR1E3 | OR1F1 | OR1F2P | OR1G1 | OR1I1 | OR1J1 | OR1J2 | OR1J4 | OR1K1 | OR1L1 | OR1L3 | OR1L4 | OR1L6 | OR1L8 | OR1M1 | OR1N1 | OR1N2 | OR1P1 | OR1Q1 | OR1S1 | OR1S2 | OR2A1 | OR2A1-AS1 | OR2A12 | OR2A14 | OR2A2 | OR2A20P | OR2A25 | OR2A4 | OR2A42 | OR2A7 | OR2A9P | OR2AE1 | OR2AG1 | OR2AG2 | OR2AJ1 | OR2AK2 | OR2AL1P | OR2AM1P | OR2AP1 | OR2AT4 | OR2B11 | OR2B2 | OR2B3 | OR2B6 | OR2C1 | OR2C3 | OR2D2 | OR2D3 | OR2F1 | OR2F2 | OR2G2 | OR2G3 | OR2G6 | OR2H1 | OR2H2 | OR2I1P | OR2J1 | OR2J2 | OR2J3 | OR2J4P | OR2K2 | OR2L13 | OR2L1P | OR2L2 | OR2L3 | OR2L5 | OR2L8 | OR2L9P | OR2M1P | OR2M2 | OR2M3 | OR2M4 | OR2M5 | OR2M7 | OR2Q1P | OR2S2 | OR2T1 | OR2T10 | OR2T11 | OR2T12